Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by SI-BONE, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: SI-BONE, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 5:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001459839-26-000056
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Gross profit | 41,944 | 37,695 |
| Operating expenses: | ||
| Sales and marketing | 32,808 | 30,681 |
| Research and development | 4,192 | 4,534 |
| General and administrative | 10,037 | 9,960 |
| Total operating expenses | 47,037 | 45,175 |
| Loss from operations | (5,093) | (7,480) |
| Interest and other income (expense), net: |
Item 1. Financial Statements
FAQ
- What is SI-BONE, Inc.'s R&D?
- SI-BONE, Inc. (SIBN) reported R&D of $4.19M in Q1 2026.
- How has SI-BONE, Inc.'s R&D changed year-over-year?
- SI-BONE, Inc.'s R&D decreased by 7.5% year-over-year, from $4.53M to $4.19M.
- What is the long-term trend for SI-BONE, Inc.'s R&D?
- Over 4 years (2021 to 2025), SI-BONE, Inc.'s R&D has grown at a 8.8% compound annual growth rate (CAGR), from $12.44M to $17.45M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about SI-BONE, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude